<DOC>
	<DOCNO>NCT02028663</DOCNO>
	<brief_summary>The purpose study investigate optimal dose administration method CJ-12420 patient erosive esophagitis compare safety efficacy orally administer CJ-12420 esomeprazole 40mg .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy CJ-12420 Patients With Erosive Esophagitis</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Aged 2070 Diagnosed Erosive Esophagitis Esophagogastroduodenoscopy ( EGD ) classify LA Grade A D within 14 day randomization treatment Patients undergo EGD Patients diagnose irritable bowel syndrome ( IBS ) , inflammatory bowel disease ( IBD ) , suspect IBS Patients take PPIs within 2 week prior study drug administration Longterm use nonsteroidal antiinï¬‚ammatory drug throughout study Clinically significant abnormal laboratory value screen</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>P-CAB</keyword>
	<keyword>APA ( Acid Pump Antagonist )</keyword>
</DOC>